UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000062324
Receipt number R000071268
Scientific Title A Randomized Study Comparing Opt-In and Opt-Out Consent Models for Resident Physician Consultations and Case Report Publication in General Internal Medicine Outpatient Clinics
Date of disclosure of the study information 2026/07/23
Last modified on 2026/07/23 23:57:14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Randomized Study Comparing Opt-In and Opt-Out Consent Models for Resident Physician Consultations and Case Report Publication in General Internal Medicine Outpatient Clinics

Acronym

OPT-CONSENT

Scientific Title

A Randomized Study Comparing Opt-In and Opt-Out Consent Models for Resident Physician Consultations and Case Report Publication in General Internal Medicine Outpatient Clinics

Scientific Title:Acronym

OPT-CONSENT Study

Region

Japan


Condition

Condition

Not applicable (study of consent procedures in general internal medicine outpatients)

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate whether the consent model (opt-in vs. opt-out) differentially affects patient consent rates for resident physician consultations and case report publication in a general internal medicine outpatient setting.

Basic objectives2

Others

Basic objectives -Others

Comparison of consent procedures (opt-in versus opt-out)

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Consent rates for resident physician consultation and case report publication at first visit, compared between the opt-in and opt-out groups

Key secondary outcomes

Age, sex, identity of the consenting person (self vs. proxy), presence of hospital admission indication, presence of cognitive impairment, presence of psychiatric history, and existing care at another department within the same institution at first visit, compared between the opt-in and opt-out groups.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Other

Interventions/Control_1

An opt-in consent form was distributed by administrative staff prior to the clinical encounter at first visit. The form addressed two items: (1) consent to be initially examined by a resident physician under the supervision of an attending physician, and (2) consent for their clinical case to be used in a published case report. Patients were required to actively indicate consent by checking a box for each item.

Interventions/Control_2

An opt-out consent form was distributed by administrative staff prior to the clinical encounter at first visit. The form addressed two items: (1) consent to be initially examined by a resident physician under the supervision of an attending physician, and (2) consent for their clinical case to be used in a published case report. Consent was presumed unless patients actively declined by checking a box for each item.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

New outpatients aged 18 years or older attending the general internal medicine outpatient clinic of Chiba Central Medical Center during the 15-month resident physician training period between April 2021 and January 2023

Key exclusion criteria

Patients were excluded if their consent form contained insufficient information to determine their response, if they declined participation in the study, or if written consent could not be obtained due to severe communication difficulties without a proxy available.

Target sample size

178


Research contact person

Name of lead principal investigator

1st name Shingo
Middle name
Last name Suzuki

Organization

Chiba Central Medical Center

Division name

Department of Internal Medicine

Zip code

264-0017

Address

1835-1 Kasori-cho, Wakaba-ku, Chiba-shi, Chiba, Japan

TEL

043-232-3691

Email

shngszkthk@yahoo.co.jp


Public contact

Name of contact person

1st name Kenta
Middle name
Last name Kanda

Organization

Chiba Central Medical Center

Division name

Department of Internal Medicine

Zip code

264-0017

Address

1835-1 Kasori-cho, Wakaba-ku, Chiba-shi, Chiba, Japan

TEL

043-232-3691

Homepage URL


Email

kenta43knd@gmail.com


Sponsor or person

Institute

Chiba Central Medical Center

Institute

Department

Personal name



Funding Source

Organization

No external funding received

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Chiba Central Medical Center IRB

Address

1835-1 Kasori-cho, Wakaba-ku, Chiba-shi, Chiba, Japan

Tel

043-232-3691

Email

resident@ccmc.seikei-kai.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 07 Month 23 Day


Related information

URL releasing protocol

Currently under preparation for journal submission.

Publication of results

Unpublished


Result

URL related to results and publications

Currently under preparation for journal submission.

Number of participants that the trial has enrolled

260

Results

A total of 252 patients were analyzed (opt-in: n=142; opt-out: n=110). Consent rates for resident physician consultation did not differ significantly between groups (opt-in 81.7% vs. opt-out 84.5%; p=0.550; RR=1.03 [95% CI 0.93-1.16]). Consent rates for case report publication were significantly higher in the opt-out group (opt-in 54.9% vs. opt-out 84.5%; p<0.001; RR=1.54 [95% CI 1.30-1.82]).

Results date posted

2026 Year 07 Month 22 Day

Results Delayed


Results Delay Reason

Not applicable

Date of the first journal publication of results


Baseline Characteristics

Opt-in group (n=142): mean age 65.0 years (SD 19.4), male 83 (58.5%), self-consent 125 (88.0%), hospital admission indicated 8 (5.7%), cognitive impairment 9 (6.4%), psychiatric history 7 (4.9%), care at another department 98 (69.0%). Opt-out group (n=110): mean age 65.7 years (SD 20.4), male 51 (46.4%), self-consent 92 (83.6%), hospital admission indicated 6 (5.5%), cognitive impairment 10 (9.1%), psychiatric history 9 (8.2%), care at another department 68 (61.8%). No significant differences between groups (all p>0.200).

Participant flow

Of 260 patients who received consent forms, 8 were excluded (1 completely blank form, 7 not uploaded to the electronic medical record), leaving 252 patients for analysis (opt-in: n=142; opt-out: n=110). Group allocation of the 8 excluded patients could not be confirmed as original paper forms were unavailable.

Adverse events

No adverse events occurred in this study.

Outcome measures

[Primary] Consent rates for resident physician consultation and case report publication immediately after completion of the consent form at first visit (opt-in vs. opt-out group)
[Secondary] Age, sex, identity of consenting person (self vs. proxy), presence of hospital admission indication, cognitive impairment, psychiatric history, and existing care at another department within the same institution at first visit

Plan to share IPD

No

IPD sharing Plan description

Not applicable


Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 02 Month 24 Day

Date of IRB

2021 Year 02 Month 24 Day

Anticipated trial start date

2021 Year 04 Month 01 Day

Last follow-up date

2023 Year 01 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This trial was retrospectively registered. At the time of study initiation, the intervention (change in consent document format) was not considered to meet the ICMJE definition of a health-related intervention requiring prospective trial registration. Registration was performed retrospectively upon preparation of the manuscript for journal submission.


Management information

Registered date

2026 Year 07 Month 23 Day

Last modified on

2026 Year 07 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071268